Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 227

1.

Galectin-3 modulation of T-cell activation: mechanisms of membrane remodelling.

Gilson RC, Gunasinghe SD, Johannes L, Gaus K.

Prog Lipid Res. 2019 Oct;76:101010. doi: 10.1016/j.plipres.2019.101010. Epub 2019 Nov 1. Review.

PMID:
31682868
2.

Pragmatic cluster randomised cohort cross-over trial to determine the effectiveness of bridging from emergency to regular contraception: the Bridge-It study protocol.

Cameron ST, Baraitser P, Glasier A, McDaid L, Norrie J, Radley A, Stephenson JM, Trussell J, Battison C, Cameron S, Cowle K, Forrest M, Gilson R, Goulao B, Johnstone A, McDonald A, Morelli A, Patterson S, Sally D, Stewart N; Bridge-It Study Group.

BMJ Open. 2019 Oct 30;9(10):e029978. doi: 10.1136/bmjopen-2019-029978.

3.

Effectiveness of Transmitted Drug Resistance Testing Before Initiation of Antiretroviral Therapy in HIV-Positive Individuals.

Lodi S, Günthard HF, Gill J, Phillips AN, Dunn D, Vu Q, Siemieniuk R, Garcia F, Logan R, Jose S, Bucher HC, Scherrer AU, Reiss P, van Sighem A, Boender TS, Porter K, Gilson R, Paraskevis D, Simeon M, Vourli G, Moreno S, Jarrin I, Sabin C, Hernán MA.

J Acquir Immune Defic Syndr. 2019 Nov 1;82(3):314-320. doi: 10.1097/QAI.0000000000002135.

PMID:
31609929
4.

No overall change in the rate of weight gain after switching to an integrase-inhibitor in virologically suppressed adults with HIV.

Burns JE, Stirrup OT, Dunn D, Runcie-Unger I, Milinkovic A, Candfield S, Lukha H, Severn A, Waters L, Edwards S, Gilson R, Pett SL.

AIDS. 2020 Jan 1;34(1):109-114. doi: 10.1097/QAD.0000000000002379.

PMID:
31567162
5.

Hyaluronidase.

Gilson RL, Zafar Gondal A.

StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2019 Jan-.
2019 Sep 15.

6.

Association of HIV status with sexual function in women aged 45-60 in England: results from two national surveys.

Toorabally N, Mercer CH, Mitchell KR, Blell M, Burns F, Gilson R, McGregor-Read J, Allan S, De Ruiter A, Dhairyawan R, Fox J, Gilleece Y, Jones R, Mackie N, Obeyesekera S, Post F, Reeves I, Rosenvinge M, Ross J, Sarner L, Sullivan A, Tariq A, Ustianowski A, Sabin CA, Tariq S.

AIDS Care. 2019 Aug 14:1-10. doi: 10.1080/09540121.2019.1653436. [Epub ahead of print]

PMID:
31411046
7.

Healthcare provider and service user perspectives on STI risk reduction interventions for young people and MSM in the UK.

Roy A, King C, Gilson R, Richardson D, Burns F, Rodger A, Clark L, Miners A, Pollard A, Desai S, Bailey J, Shahmanesh M, Llewellyn C.

Sex Transm Infect. 2019 Jul 26. pii: sextrans-2018-053903. doi: 10.1136/sextrans-2018-053903. [Epub ahead of print]

8.

Scabies (Sarcoptes Scabiei).

Gilson RL, Basit H, Soman-Faulkner K.

StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2019 Jan-.
2019 Jul 22.

9.

Predicting STI Diagnoses Amongst MSM and Young People Attending Sexual Health Clinics in England: Triage Algorithm Development and Validation Using Routine Clinical Data.

King C, Hughes G, Furegato M, Mohammed H, Were J, Copas A, Gilson R, Shahmanesh M, Mercer CH.

EClinicalMedicine. 2018 Nov 28;4-5:43-51. doi: 10.1016/j.eclinm.2018.11.002. eCollection 2018 Oct-Nov.

11.

Trafficking of a Single Photosensitizing Molecule to Different Intracellular Organelles Demonstrates Effective Hydroxyl Radical-Mediated Photodynamic Therapy in the Endoplasmic Reticulum.

Gilson RC, Tang R, Gautam KS, Grabowska D, Achilefu S.

Bioconjug Chem. 2019 May 15;30(5):1451-1458. doi: 10.1021/acs.bioconjchem.9b00192. Epub 2019 Apr 30.

PMID:
31009564
12.

Changes in chemsex and sexual behaviour over time, among a cohort of MSM in London and Brighton: Findings from the AURAH2 study.

Sewell J, Cambiano V, Speakman A, Lampe FC, Phillips A, Stuart D, Gilson R, Asboe D, Nwokolo N, Clarke A, Rodger AJ.

Int J Drug Policy. 2019 Jun;68:54-61. doi: 10.1016/j.drugpo.2019.03.021. Epub 2019 Apr 15.

13.

Sexual risk reduction interventions for patients attending sexual health clinics: a mixed-methods feasibility study.

King C, Llewellyn C, Shahmanesh M, Abraham C, Bailey J, Burns F, Clark L, Copas A, Howarth A, Hughes G, Mercer C, Miners A, Pollard A, Richardson D, Rodger A, Roy A, Gilson R.

Health Technol Assess. 2019 Mar;23(12):1-122. doi: 10.3310/hta23120.

14.

Implementation and evaluation of the human papillomavirus (HPV) vaccination pilot for men who have sex with men (MSM), England, April 2016 to March 2017.

Edelstein M, Iyanger N, Hennessy N, Mesher D, Checchi M, Soldan K, McCall M, Nugent J, Crofts J, Lo J, Gilson R, Powell K, Ramsay M, Yarwood J.

Euro Surveill. 2019 Feb;24(8). doi: 10.2807/1560-7917.ES.2019.24.8.1800055.

15.

Gender-neutral HPV vaccination in the UK, rising male oropharyngeal cancer rates, and lack of HPV awareness.

Lechner M, Jones OS, Breeze CE, Gilson R.

Lancet Infect Dis. 2019 Feb;19(2):131-132. doi: 10.1016/S1473-3099(18)30802-8. Epub 2019 Jan 30. No abstract available.

PMID:
30722999
16.

Magnetic Resonance Imaging of Cerebral Small Vessel Disease in Men Living with HIV and HIV-Negative Men Aged 50 and Above.

Haddow LJ, Sudre CH, Sokolska M, Gilson RC, Williams IG, Golay X, Ourselin S, Winston A, Sabin CA, Cardoso MJ, Jäger HR; Pharmacokinetics and clinical Observations in PeoPle over fiftY (POPPY) Study Group.

AIDS Res Hum Retroviruses. 2019 May;35(5):453-460. doi: 10.1089/AID.2018.0249. Epub 2019 Feb 20.

PMID:
30667282
17.

Challenges to optimising uptake and delivery of a HPV vaccination programme for men who have sex with men.

Forster AS, Gilson R.

Hum Vaccin Immunother. 2019;15(7-8):1541-1543. doi: 10.1080/21645515.2018.1560783. Epub 2019 Jan 30.

18.
19.

The Context of Sexual Risk Behaviour Among Men Who Have Sex with Men Seeking PrEP, and the Impact of PrEP on Sexual Behaviour.

Gafos M, Horne R, Nutland W, Bell G, Rae C, Wayal S, Rayment M, Clarke A, Schembri G, Gilson R, McOwan A, Sullivan A, Fox J, Apea V, Dewsnap C, Dolling D, White E, Brodnicki E, Wood G, Dunn D, McCormack S.

AIDS Behav. 2019 Jul;23(7):1708-1720. doi: 10.1007/s10461-018-2300-5.

20.

Madelung lipomatosis presenting as a manifestation of myoclonic epilepsy with ragged red fibers (MERRF) syndrome.

Gilson RC, Osswald S.

JAAD Case Rep. 2018 Sep 18;4(8):822-823. doi: 10.1016/j.jdcr.2018.05.004. eCollection 2018 Sep. No abstract available.

21.

A cross-sectional survey of awareness of human papillomavirus-associated oropharyngeal cancers among general practitioners in the UK.

Lechner M, Vassie C, Kavasogullari C, Jones O, Howard J, Masterson L, Fenton T, Yarbrough W, Waller J, Gilson R.

BMJ Open. 2018 Jul 28;8(7):e023339. doi: 10.1136/bmjopen-2018-023339.

22.

Growth of Plasmodium falciparum in response to a rotating magnetic field.

Gilson RC, Deissler RJ, Bihary RF, Condit WC, Thompson ME, Blankenship D, Grimberg KO, Brown RW, Grimberg BT.

Malar J. 2018 May 3;17(1):190. doi: 10.1186/s12936-018-2333-2.

23.

Changes in recreational drug use, drug use associated with chemsex, and HIV-related behaviours, among HIV-negative men who have sex with men in London and Brighton, 2013-2016.

Sewell J, Cambiano V, Miltz A, Speakman A, Lampe FC, Phillips A, Stuart D, Gilson R, Asboe D, Nwokolo N, Clarke A, Hart G, Rodger A.

Sex Transm Infect. 2018 Nov;94(7):494-501. doi: 10.1136/sextrans-2017-053439. Epub 2018 Apr 26.

24.

Designing a brief behaviour change intervention to reduce sexually transmitted infections: a discrete choice experiment.

Miners A, Llewellyn C, King C, Pollard A, Roy A, Gilson R, Rodger A, Burns F, Shahmanesh M.

Int J STD AIDS. 2018 Aug;29(9):851-860. doi: 10.1177/0956462418760425. Epub 2018 Apr 8.

25.

Dementia, diarrhea, desquamating shellac-like dermatitis revealing late-onset cobalamin C deficiency.

Gilson RC, Wallis L, Yeh J, Gilson RT.

JAAD Case Rep. 2017 Dec 20;4(1):91-94. doi: 10.1016/j.jdcr.2017.09.016. eCollection 2018 Jan. No abstract available.

26.

Sexualized drug use ('chemsex') and high-risk sexual behaviours in HIV-positive men who have sex with men.

Pufall EL, Kall M, Shahmanesh M, Nardone A, Gilson R, Delpech V, Ward H; Positive Voices study group.

HIV Med. 2018 Apr;19(4):261-270. doi: 10.1111/hiv.12574. Epub 2018 Jan 24.

27.

Dapsone for Recalcitrant Eosinophilic Annular Erythema: A Case Report and Literature Review.

Wallis L, Gilson RC, Gilson RT.

Dermatol Ther (Heidelb). 2018 Mar;8(1):157-163. doi: 10.1007/s13555-017-0214-1. Epub 2017 Dec 8.

28.

Enhancing proteasome-inhibitory activity and specificity of bortezomib by CD38 targeted nanoparticles in multiple myeloma.

de la Puente P, Luderer MJ, Federico C, Jin A, Gilson RC, Egbulefu C, Alhallak K, Shah S, Muz B, Sun J, King J, Kohnen D, Salama NN, Achilefu S, Vij R, Azab AK.

J Control Release. 2018 Jan 28;270:158-176. doi: 10.1016/j.jconrel.2017.11.045. Epub 2017 Nov 28.

29.

Measurement of Retinal Vessels as a Biomarker of Cerebrovascular Aging in Older HIV-Positive Men Compared With Controls.

Haddow L, Laverick R, Leung I, Post F, Vera J, Gilson R, Williams I, Boffito M, Sabin C, Winston A, Peto T.

J Acquir Immune Defic Syndr. 2018 Feb 1;77(2):199-205. doi: 10.1097/QAI.0000000000001570.

PMID:
29040166
30.

Self-Reported Decline in Everyday Function, Cognitive Symptoms, and Cognitive Function in People With HIV.

Laverick R, Haddow L, Daskalopoulou M, Lampe F, Gilson R, Speakman A, Antinori A, Bruun T, Vassilenko A, Collins S, Rodger A; Cognitive Impairment in People with HIV in the European Region (CIPHER) Study Group.

J Acquir Immune Defic Syndr. 2017 Nov 1;76(3):e74-e83. doi: 10.1097/QAI.0000000000001468.

PMID:
29016449
31.

Hepatitis B, hepatitis C, and mortality among HIV-positive individuals.

Thornton AC, Jose S, Bhagani S, Chadwick D, Dunn D, Gilson R, Main J, Nelson M, Rodger A, Taylor C, Youssef E, Leen C, Gompels M, Kegg S, Schwenk A, Sabin C; UK Collaborative HIV cohort (UK CHIC) steering committee.

AIDS. 2017 Nov 28;31(18):2525-2532. doi: 10.1097/QAD.0000000000001646.

32.

Prospective observational study to evaluate the performance of the BioSure HIV Self-Test in the hands of lay users.

Saunders J, Brima N, Orzol M, Phillips L, Milinkovic A, Carpenter G, Copas A, Gilson R.

Sex Transm Infect. 2018 May;94(3):169-173. doi: 10.1136/sextrans-2017-053231. Epub 2017 Sep 18.

PMID:
28924053
33.

Early virological response to HIV treatment: can we predict who is likely to experience subsequent treatment failure? Results from an observational cohort study, London, UK.

Brima N, Lampe FC, Copas A, Gilson R, Williams I, Johnson MA, Phillips AN, Smith CJ.

J Int AIDS Soc. 2017 Aug 30;20(1):21567. doi: 10.7448/IAS.20.21567.

34.

A qualitative study exploring the social and environmental context of recently acquired HIV infection among men who have sex with men in South-East England.

Gourlay A, Fox J, Gafos M, Fidler S, Nwokolo N, Clarke A, Gilson R, Orkin C, Collins S, Porter K, Hart G.

BMJ Open. 2017 Aug 28;7(8):e016494. doi: 10.1136/bmjopen-2017-016494. Erratum in: BMJ Open. 2017 Dec 22;7(12 ):e016494corr1.

35.

Demand for pre-exposure prophylaxis for HIV and the impact on clinical services: Scottish men who have sex with men perspectives.

Gilson RI, Clutterbuck DJ, Chen ZE.

Int J STD AIDS. 2018 Mar;29(3):273-277. doi: 10.1177/0956462417723817. Epub 2017 Aug 3.

PMID:
28771076
36.

A sheep in wolf's clothing?

Rahnama-Moghadam S, Gilson RT.

J Fam Pract. 2017 Jul;66(7):E1-E4.

PMID:
28700764
37.

Hybrid TiO2 -Ruthenium Nano-photosensitizer Synergistically Produces Reactive Oxygen Species in both Hypoxic and Normoxic Conditions.

Gilson RC, Black KCL, Lane DD, Achilefu S.

Angew Chem Int Ed Engl. 2017 Aug 28;56(36):10717-10720. doi: 10.1002/anie.201704458. Epub 2017 Jul 26.

38.

Clinically significant depressive symptoms and sexual behaviour among men who have sex with men.

Miltz AR, Rodger AJ, Sewell J, Speakman A, Phillips AN, Sherr L, Gilson RJ, Asboe D, Nwokolo NC, Clarke A, Gompels MM, Allan S, Collins S, Lampe FC; AURAH Study Group.

BJPsych Open. 2017 May 8;3(3):127-137. doi: 10.1192/bjpo.bp.116.003574. eCollection 2017 May.

39.

Pruritic rash on the buttock.

Osswald B, Gilson RT.

Cutis. 2017 Apr;99(4):232;262;264. No abstract available.

PMID:
28492597
40.

Randomized controlled trial of the tolerability and completion of maraviroc compared with Kaletra® in combination with Truvada® for HIV post-exposure prophylaxis (MiPEP Trial).

Milinkovic A, Benn P, Arenas-Pinto A, Brima N, Copas A, Clarke A, Fisher M, Schembri G, Hawkins D, Williams A, Gilson R; MiPEP Trial Team.

J Antimicrob Chemother. 2017 Jun 1;72(6):1760-1768. doi: 10.1093/jac/dkx062.

PMID:
28369381
41.

Until eradication, awareness.

Jones OS, Vassie C, Gilson R, Lechner M.

Lancet Infect Dis. 2017 Apr;17(4):368-369. doi: 10.1016/S1473-3099(17)30125-1. No abstract available.

PMID:
28346176
42.

Hepatitis B serological markers and plasma DNA concentrations.

Price H, Dunn D, Zachary T, Vudriko T, Chirara M, Kityo C, Munderi P, Spyer M, Hakim J, Gilks C, Kaleebu P, Pillay D, Gilson R; DART Virology Group.

AIDS. 2017 May 15;31(8):1109-1117. doi: 10.1097/QAD.0000000000001454.

43.

Socioeconomic status and treatment outcomes for individuals with HIV on antiretroviral treatment in the UK: cross-sectional and longitudinal analyses.

Burch LS, Smith CJ, Anderson J, Sherr L, Rodger AJ, O'Connell R, Geretti AM, Gilson R, Fisher M, Elford J, Jones M, Collins S, Azad Y, Phillips AN, Speakman A, Johnson MA, Lampe FC.

Lancet Public Health. 2016 Nov;1(1):e26-e36. doi: 10.1016/S2468-2667(16)30002-0.

44.

Poly drug use, chemsex drug use, and associations with sexual risk behaviour in HIV-negative men who have sex with men attending sexual health clinics.

Sewell J, Miltz A, Lampe FC, Cambiano V, Speakman A, Phillips AN, Stuart D, Gilson R, Asboe D, Nwokolo N, Clarke A, Collins S, Hart G, Elford J, Rodger AJ; Attitudes to and Understanding of Risk of Acquisition of HIV (AURAH) Study Group.

Int J Drug Policy. 2017 May;43:33-43. doi: 10.1016/j.drugpo.2017.01.001. Epub 2017 Feb 10.

PMID:
28189979
45.

Multicenter European Prevalence Study of Neurocognitive Impairment and Associated Factors in HIV Positive Patients.

Haddow LJ, Laverick R, Daskalopoulou M, McDonnell J, Lampe FC, Gilson R, Speakman A, Antinori A, Balestra P, Bruun T, Gerstoft J, Nielsen L, Vassilenko A, Collins S, Rodger AJ; Cognitive Impairment in People with HIV in the European Region (CIPHER) Study Group.

AIDS Behav. 2018 May;22(5):1573-1583. doi: 10.1007/s10461-017-1683-z.

46.

Erythematous Subcutaneous Nodules in a Neonate.

McDonald HH, Dehesa L, Gilson RT.

Pediatr Dermatol. 2017 Jan;34(1):103-104. doi: 10.1111/pde.13043. No abstract available.

PMID:
28054721
47.

Impact and Cost-effectiveness of Selective Human Papillomavirus Vaccination of Men Who Have Sex With Men.

Lin A, Ong KJ, Hobbelen P, King E, Mesher D, Edmunds WJ, Sonnenberg P, Gilson R, Bains I, Choi YH, Tanton C, Soldan K, Jit M.

Clin Infect Dis. 2017 Mar 1;64(5):580-588. doi: 10.1093/cid/ciw845.

48.

Erratum to "Brief interventions to prevent sexually transmitted infections suitable for in-service use: A systematic review" [Prev. Med. 91 (2016) 364-382].

Long L, Abraham C, Paquette R, Shahmanesh M, Llewellyn C, Townsend A, Gilson R.

Prev Med. 2017 Mar;96:163-164. doi: 10.1016/j.ypmed.2016.11.031. Epub 2016 Dec 9. No abstract available.

PMID:
27956010
49.

Where next with preexposure prophylaxis?

Nugent D, Gilson R.

Curr Opin Infect Dis. 2017 Feb;30(1):44-49. doi: 10.1097/QCO.0000000000000340. Review.

PMID:
27870645
50.

Non-Disclosure of HIV Status and Associations with Psychological Factors, ART Non-Adherence, and Viral Load Non-Suppression Among People Living with HIV in the UK.

Daskalopoulou M, Lampe FC, Sherr L, Phillips AN, Johnson MA, Gilson R, Perry N, Wilkins E, Lascar M, Collins S, Hart G, Speakman A, Rodger AJ; ASTRA Study Group.

AIDS Behav. 2017 Jan;21(1):184-195. doi: 10.1007/s10461-016-1541-4.

Supplemental Content

Loading ...
Support Center